Administration of multimeric sPD-L2 in a mouse model of malaria resulted in enhanced malaria specific CD4+ T-cells and improved clinical outcomes, but similar effects to malaria-specific CD8+ T-cells were not observed (39). Here, CD4 is linked to malaria.